Objectives: The integration of machine learning and radiomics in medical imaging has significantly advanced diagnostic and prognostic capabilities in healthcare. This study focuses on developing and validating an artificial intelligence (AI) model using U-Net architectures for the accurate detection and segmentation of spinal metastases from computed tomography (CT) images, addressing both osteolytic and osteoblastic lesions. Methods: Our methodology employs multiple variations of the U-Net architecture and utilizes two distinct datasets: one consisting of 115 polytrauma patients for vertebra segmentation and another comprising 38 patients with documented spinal metastases for lesion detection. Results: The model demonstrated strong performance in vertebra segmentation, achieving Dice Similarity Coefficient (DSC) values between 0.87 and 0.96. For metastasis segmentation, the model achieved a DSC of 0.71 and an F-beta score of 0.68 for lytic lesions but struggled with sclerotic lesions, obtaining a DSC of 0.61 and an F-beta score of 0.57, reflecting challenges in detecting dense, subtle bone alterations. Despite these limitations, the model successfully identified isolated metastatic lesions beyond the spine, such as in the sternum, indicating potential for broader skeletal metastasis detection. Conclusions: The study concludes that AI-based models can augment radiologists’ capabilities by providing reliable second-opinion tools, though further refinements and diverse training data are needed for optimal performance, particularly for sclerotic lesion segmentation. The annotated CT dataset produced and shared in this research serves as a valuable resource for future advancements.

The objective of this study was to develop and evaluate artificial intelligence (AI) models for the detection and instance segmentation of vertebrae and spinal metastases in computer tomography (CT) scans. The models were trained on datasets consisting of patients with polytrauma and relatively undamaged spines, as well as patients diagnosed with spinal metastases. Our results indicate that the models achieved high performance in vertebra segmentation, with F-beta scores ranging from 0.88 to 0.96 across all vertebra classes. For spinal metastases, the model attained F-beta scores of 0.68 for lytic type and 0.57 for sclerotic type metastases. Additionally, the models demonstrated the capability to detect isolated metastatic nodes in other bones, highlighting their robustness and potential for broader clinical application. Despite these promising results, the study faced limitations including a relatively small and homogeneous dataset, variability in segmentation mask quality, and the need for real-world clinical validation. Future clinical trials are necessary to evaluate the practical utility and effectiveness of these AI models in improving patient outcomes. Our study emphasizes the potential of AI-assisted detection and segmentation models in enhancing diagnostic accuracy and efficiency in clinical practice.